Diagnosis and Management of Parkinson's Disease

Seminars in Neurology
Arjun Tarakad, Joseph Jankovic

Abstract

Despite numerous efforts to identify specific and sensitive biomarkers, the diagnosis of Parkinson's disease (PD) is still based on clinical criteria that include the presence of a combination of cardinal motor features (tremor, rigidity, bradykinesia, and postural instability), other motor features (including freezing of gait and abnormal postures), and numerous nonmotor features. In addition, the presence of atypical features may suggest an alternative diagnosis. Levodopa therapy remains the gold standard in the management of motor features of PD. New formulations of levodopa and novel delivery systems are currently being evaluated and gradually introduced in clinical practice in an attempt to prevent or treat levodopa-related motor complications. Dopamine agonists also play an important role as monotherapy in mild or adjunctive therapy in moderately advanced disease. As the disease progresses and patients develop complications from levodopa therapy, specifically motor fluctuations and dyskinesias, deep brain stimulation becomes an alternative therapeutic option. Clinical trials of experimental therapeutics are currently fueling the PD therapeutic pipeline.

Citations

Dec 21, 2017·Immunotherapy·Joseph Jankovic
Apr 25, 2020·The International Journal of Neuroscience·Ersin Kasım Ulusoy, Döndü Melek Ulusoy
Oct 5, 2017·Current Neurology and Neuroscience Reports·Gennaro PaganoMarios Politis
May 30, 2020·Nature Reviews. Drug Discovery·Linda PartridgeBrian K Kennedy
Jun 13, 2020·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Liuna YangJialong Chen
Jun 2, 2020·Chinese Journal of Integrative Medicine·Wen-Wei Li
Jul 29, 2017·F1000Research·Maxime W C RousseauxJoseph Jankovic
Jun 26, 2020·Frontiers in Human Neuroscience·Shelby SabourinJulie G Pilitsis
Nov 30, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Joseph Jankovic
Mar 25, 2019·Frontiers in Integrative Neuroscience·Márcia Regina MottaJosé Lino Oliveira Bueno
Sep 11, 2020·Journal of Oleo Science·Claudia Cecilia Pazos-TomasIván Antonio García-Montalvo
Dec 16, 2020·Neural Regeneration Research·Jolanta DorszewskaWojciech Kozubski
Jul 6, 2019·Parkinsonism & Related Disorders·Nicki Niemann, Joseph Jankovic
Jan 19, 2021·Journal of Neuromuscular Diseases·Laura OverKatja Lohmann
Mar 6, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ya-Shuo FengFeng Zhang
Mar 31, 2021·Scientific Reports·Antonio M Durán-RosalCésar Hervás-Martínez
Jul 3, 2021·International Journal of Molecular Sciences·Sri JayantiSilvia Gazzin
Jul 17, 2021·Neurochemistry International·Sidrah Tariq KhanAhmed Al-Harrasi
Aug 24, 2021·Frontiers in Aging Neuroscience·Maria Shadrina, Petr Slominsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain-Computer Interface

A brain-computer interface, also known as a brain-machine interface, is a bi-directional communication pathway between an external device and a wired brain. Here is the latest research on this topic.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Mark GuttmanYoshiaki Furukawa
Expert Review of Neurotherapeutics
Alan Diamond, Joseph Jankovic
© 2022 Meta ULC. All rights reserved